Several years ago, a little-known drug named Ozempic – previously used only to treat diabetes – emerged as a promising new ...

Weight-loss medications called glucagon-like peptide-1 (GLP-1) receptor agonists include Ozempic, Mounjaro, Wegovy and Zepbound—and they can be prescribed for obesity or type 2 diabetes.

The U.S. government named 15 drugs that will be subject to the second round of price negotiations by Medicare, including Ozempic and Wegovy, the drugs at the center of the weight-loss craze.